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The exquisite specificity exhibited by many proteins for their
respective ligands can often be attributed to particular structural
features within the binding site. The Src homology 2 (SH2) domain
of interleukin-2 tyrosine kinase (Itk) contains overlapping binding
sites capable of mediating binding to two distinct ligands: a
phosphotyrosine-containing peptide and the Itk Src homology 3
(SH3) domain1 (Figure 1a). We have previously demonstrated that
the Asn 286-Pro 287 imide bond in the Itk SH2 domain adopts
both the cis and trans conformations in solution.2,3 Exchange
between the conformers is slow on the NMR time scale, leading to
the appearance of doubled resonances in NMR spectra for 35 of
the 109 SH2 residues (Figure 1b). The structural changes induced
by isomerization of the peptidyl prolyl imide bond in the Itk SH2
domain modulate its affinity for both of its ligands. We now report
a quantitative study of the equilibria governing the peptidyl prolyl
cis/trans isomerization and concomitant ligand binding to the Itk
SH2 domain. Hereafter, we will refer to the cis and trans imide
bond containing SH2 conformers as the cis and trans conformers,
respectively.
The conformer-specific nature of Itk SH2 ligand recognition is
evident in NMR spectra of the protein/ligand complexes. Addition
of phosphopeptide to the Itk SH2 domain shifts the equilibrium to
favor the trans conformer, resulting in changes in the volumes of
the NMR peaks corresponding to each conformer (Figure 1c). Also,
ligand-induced chemical shift changes are larger for cross-peaks
corresponding to residues in the trans conformer than for those
corresponding to residues in the cis conformer. In contrast, binding
of the Itk SH3 domain to the SH2 domain shifts the cis/trans ratio
to favor the cis conformer (Figure 1d). In this case, shifts in the
positions of cross-peaks corresponding to the cis conformer (but
not those of the trans conformer) are observed in the HSQC
spectrum of the Itk SH2 domain to which recombinant Itk SH3
domain has been added2. To our knowledge, this is the first
demonstration of ligand recognition that is governed by the
conformation of a single prolyl imide bond within a folded protein.
However, a qualitative analysis of the data cannot establish that
the trans SH2 conformer has no affinity for the Itk SH3 domain or
that the cis conformer cannot bind phosphopeptide. We have
therefore developed a method of analyzing chemical shift perturba-
tion and cross-peak volumes to measure the binding affinities of
both ligands for each SH2 conformer.
The simplest model for SH2 binding to either ligand is given by
eq 1:
where P is the protein (Itk SH2), L the ligand (phosphopeptide or
Itk SH3), PL the protein/ligand complex, and Ko the observed
association constant. Both Itk SH2/ligand binding events are in the
fast exchange regime such that the resonance frequencies of reporter
residues (residues involved in binding of the ligand) are a
population-weighted average of the bound and unbound frequencies.
The dependence of resonance frequency on ligand concentration
can be used to extract Ko. It is incorrect, though, to use an exchange-
doubled resonance as a reporter, because the concentrations of the
cis and trans conformers will vary over the course of the titration.
Therefore, five well-resolved SH2 cross-peaks unaffected by proline
isomerization (N241, Y292, V311, F312, and L318) were used to
determine Ko for Itk SH2 phosphopeptide binding (Figure 2a, Table
1). In the case of Itk SH3 binding, all Itk SH2 peaks that exhibit
measurable chemical shifts are affected by the cis/trans isomeriza-
tion of Pro 287. Ko was therefore measured for this system by
analysis of the NMR data acquired using the reverse labeling
scheme (unlabeled SH2 domain titrated into 15N-labeled SH3
domain). The concentration dependence of the normalized chemical
shifts for five SH3 cross-peaks (Y180, W208, W209, A221, and
S223) are shown in Figure 2b, and Ko for the association is reported
in Table 1.
To determine the affinities of the SH2 conformers for each of
the two ligands, we analyzed the fraction of Itk SH2 domain bound
to ligand (fb, concentration of ligand-bound SH2 divided by total
SH2 concentration) and the fraction in the cis conformer (fc,
concentration of cis imide bond-containing SH2sin both bound
and unbound formssdivided by total SH2 concentration). Using
† Department of Biochemistry, Biophysics and Molecular Biology.
‡ Program of Bioinformatics and Computational Biology.
§ Department of Chemical Engineering.
P + L y\z
Ko
PL (1)
Figure 1. (a) Surface representation of the cis SH2 domain. The residues
whose chemical shifts change upon Itk SH3 binding are white, while those
unaffected are orange. The region bound by the dotted line indicates the
residues that are affected by binding to the phosphotyrosine-containing
peptide ADpYEPPPSNDE. The position of Pro 287 is indicated. (b) Select
region of the heteronuclear single quantum coherence (HSQC) spectrum
showing the doubled resonances for Lys 258 of the Itk SH2 domain. The
cross-peak corresponding to the trans conformer is downfield compared to
the cis in both the 1H and 15N dimensions. The integrated volume ratio of
the cis and trans cross-peaks (Ic/It) is equal to 0.64 ( 0.06. (c) Corresponding
region for 15N-labeled Itk SH2 domain following addition of a 20-fold excess
of phosphopeptide (Ic/It ) 0.22 ( 0.07). (d) Corresponding region for 15N-
labeled Itk SH2 domain following addition of a 7-fold excess of the Itk
SH3 domain (Ic/It ) 1.60 ( 0.19).
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the observed association constants (Table 1), we can compute fb
for each point of the titration, while fc is measured by integrating
the volumes of the cis and trans cross-peaks of Itk SH2 residues
affected by isomerization. A plot of fc versus fb yields a straight
line (Figure 3). If the Itk SH3 domain bound exclusively to the cis
Itk SH2 conformer, then fb ) 1 would result in fc ) 1. Similarly,
for the phosphotyrosine titration, at fb ) 1 a value of fc ) 0 is
expected if only the trans SH2 conformer is able to bind phospho-
peptide. This is not the case for either the phosphopeptide or Itk
SH3 titrations (Figure 3, parts a and b, respectively), indicating
that both SH2 conformers (cis and trans) have measurable affinity
for each of the ligands as represented in the following equilibrium
model (eqs 2-4):
where the t and c superscripts refer to the trans and cis conformers,
respectively. The trans to cis interconversion constant K′ is given
by the integrated volume ratio of the cis and trans cross-peaks of
free Itk SH2 (0.64 ( 0.06, see Figure 1). The equilibrium model
given by eqs 2-4 predicts a relationship between fc and fb, which
can be used to determine the equilibrium constants Kc and Kt
(derivation in the Supporting Information):
Kc and Kt are then obtained by fitting eq 5 to the cis/trans peak
integral data of five cis/trans pairs (Figure 3). The solid line in
Figure 3 represents the fitted model, and the affinities of the cis
and trans SH2 conformers for both ligands are reported in Table 1.
Quantitative analysis of the NMR data reveals the extent to which
ligand-binding affinities are modulated by isomerization between
Itk SH2 conformers. The cis SH2 conformer exhibits a 3.5-fold
higher affinity for the Itk SH3 domain compared to binding of the
trans SH2 conformer to the same ligand. Likewise, the trans SH2
conformer binds phosphopeptide with a 4-fold greater affinity than
the corresponding cis SH2 conformer. Thus, for the Itk SH2 domain,
cis/trans isomerization of a single prolyl imide bond affords this
small domain the ability to control the relative binding affinities
for distinct ligands during cell signaling. Additional examples of
protein-binding modules that exhibit recognition of distinct targets
have been previously reported.5,6 The Itk SH2 domain represents
the first example of dual ligand recognition controlled by proline
cis/trans isomerization within the receptor. Given the intrinsic nature
of proline isomerization and the modest energy barrier between
conformers, proline cis/trans isomerization may be a general
mechanism allowing for diversity in protein recognition.
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Figure 2. Concentration dependence of normalized chemical shifts for (a)
titration of phosphopeptide into 15N-labeled Itk SH2 domain (0.32 mM)
and (b) titration of unlabeled Itk SH2 domain into 15N-labeled Itk SH3
(0.32 mM). In both cases, the curves depict the best fit of the model defined
by eq 1 to the data (see Supporting Information). Error bars represent two
standard deviations about the mean.
Table 1. Observed, Cis, and Trans Association Constants for the
SH2 Ligands
Itk SH2 binding phosphopeptide Itk SH2 binding SH3
Ko (mM-1) 2.9 ( 0.1 1.5 ( 0.1
Kc (mM-1) 1.0 ( 0.2 2.6 ( 0.3
Kt (mM-1) 4.0 ( 0.2 0.8 ( 0.2
Pt + L y\z
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fc ) ( K′(Kc - Kt)(1 + K′)(Kt + KcK′))fb + K′1 + K′ (5)
Figure 3. Plot of the fraction of cis Itk SH2 (fc) versus the total fraction
bound of ligand (fb) for (a) titration of phosphopeptide into a sample
containing 15N Itk SH2 domain and (b) titration of the Itk SH3 domain
into a sample containing 15N Itk SH2 domain. The well-resolved resonances
corresponding to residues T256, K258, G257, F278, and G260 were used
in (a) and C288, K258, G257, K290, and G260 were used in (b). Error
bars represent two standard deviations about the mean. The solid line is
the fit of eq 5 to the data. The dotted line represents the expected fraction
of cis if phosphopeptide exclusively bound the trans conformer (Kc ) 0) in
(a) or Itk SH3 exclusively bound the cis conformer (Kt ) 0) in (b).
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